Global Medtech Guidance Tracker: August 2022
Executive Summary
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-three documents have been posted on the tracker since its last update.
You may also be interested in...
FDA Urges Stronger Labeling For Hydrogen Peroxide-Based Contact Lens Solutions
New draft guidance from the US agency calls for manufacturers to add more information about potential risks to the labeling of some types of contact lens solution.
No Quick Fix When It Comes To EU Medtech Notified Body Designations
Latest information from the European Commission suggest that future notified bodies designated under the MDR, and even the IVDR, may not be in a position to issue certificates until March 2023.
‘Decentralized Clinical Trials 2.0’ On The Horizon
The remarkable shift towards decentralized clinical trials in the last three years is a testament to how this patient-centric approach of doing research has the potential to solve multiple issues such as time, cost and low participation rates. In this first segment of a two-part article, Pink Sheet looks at how innovation in this sector has just begun and we can expect more action ahead.